Charles Schwab’s Zymergen Inc. Common Stock ZY Stock Holding History

Charles Schwab’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-320,409	Closed	-$891K	–	3609
2022 Q3	$891K	Buy	320,409 +256,265	+400%	+$622K	﹤0.01%	2823
2022 Q2	$79K	Sell	64,144 -193,571	-75%	-$325K	﹤0.01%	3312
2022 Q1	$745K	Buy	257,715 +2,102	+0.8%	+$8.93K	﹤0.01%	2965
2021 Q4	$1.71M	Buy	255,613 +145,432	+132%	+$1.41M	﹤0.01%	2747
2021 Q3	$1.45M	Sell	110,181 -6,109	-5%	-$130K	﹤0.01%	2765
2021 Q2	$4.65M	Buy	+116,290	New	+$4.59M	﹤0.01%	2385

Charles Schwab's ZY Position: Q4 2022 in Review

Charles Schwab sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 320,409 shares — an estimated $891K sold.

Charles Schwab first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $4.65M in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

Charles Schwab reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Charles Schwab sold 320,409 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $891K.
Charles Schwab first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Charles Schwab's Zymergen Inc. Common Stock position peaked at $4.65M in Q2 2021.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Charles Schwab's 13F filing for Q4 2022, filed 13 Feb 2023.